(Q46502308)

22 December 2017

title

Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy (English)

1 reference

22 December 2017

author name string

Michael A Becker

1

1 reference

22 December 2017

Patricia A MacDonald

2

1 reference

22 December 2017

Barbara J Hunt

3

1 reference

22 December 2017

Christopher Lademacher

4

1 reference

22 December 2017

Nancy Joseph-Ridge

5

1 reference

22 December 2017

publication date

1 June 2008

1 reference

22 December 2017

Nucleosides, Nucleotides & Nucleic Acids

published in

1 reference

22 December 2017

volume

27

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

585-591

1 reference

22 December 2017

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15257770802136032

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770802136032

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770802136032

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770802136032

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770802136032

10.1080/15257770802136032

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017